Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00452309 · ClinicalTrials.gov registry record

Validation of a Correction Factor for Measurement of an Accurate Ankle-Brachial Index in the Seated Position

A clinical trial, sponsored by The Cleveland Clinic.

Completed
Registry status
50
Enrollment target

NCT00452309: Completed study, sponsored by The Cleveland Clinic.

NCT00452309 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00452309 has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

The purpose of this study is to test a correction factor which would allow ankle brachial indexes taken in the seated position to accurately predict an ankle brachial index taken in the supine position.

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2007-03
Est. Completion 2007-08
The Cleveland Clinic

688 total trials

What the finished NCT00452309 record still lists

NCT00452309 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00452309 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00452309 about?

NCT00452309 is a clinical study titled "Validation of a Correction Factor for Measurement of an Accurate Ankle-Brachial Index in the Seated Position". The purpose of this study is to test a correction factor which would allow ankle brachial indexes taken in the seated position to accurately predict an ankle brachial index taken in the supine position.

What is the current status of trial NCT00452309?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2007-03. Estimated completion is 2007-08.

Who is sponsoring clinical trial NCT00452309?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00452309, the US trial registry maintained by the National Library of Medicine. NCT00452309 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.